Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Schilling FH"" wg kryterium: Autor


Wyświetlanie 1-11 z 11
Tytuł:
A Novel GATA1 Variant in the C-Terminal Zinc Finger Compared with the Platelet Phenotype of Patients with A Likely Pathogenic Variant in the N-Terminal Zinc Finger.
Autorzy:
Bastida JM; Departmento de Hematología, Complejo Asistencial Universitario de Salamanca (CAUSA), Instituto de Investigación Biomédica de Salamanca (IBSAL), Universidad de Salamanca (USAL), 37007 Salamanca, Spain.
Malvestiti S; Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, Faculty of Medicine, Medical Center-University of Freiburg, 79106 Freiburg, Germany.
Boeckelmann D; Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, Faculty of Medicine, Medical Center-University of Freiburg, 79106 Freiburg, Germany.
Palma-Barqueros V; Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Pascual Parrilla, CIBERER-U765, 30003 Murcia, Spain.
Wolter M; Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, Faculty of Medicine, Medical Center-University of Freiburg, 79106 Freiburg, Germany.
Lozano ML; Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Pascual Parrilla, CIBERER-U765, 30003 Murcia, Spain.
Glonnegger H; Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, Faculty of Medicine, Medical Center-University of Freiburg, 79106 Freiburg, Germany.
Benito R; Instituto de Investigación Biomédica de Salamanca (IBSAL), Instituto de Biología Molecular y Cellular del Cáncer (IBMCC), Centro de Investigación del Cáncer (CIC), Universidad de Salamanca-Consejo Superior de Investigaciones Cientificas (CSIC), 37007 Salamanca, Spain.
Zaninetti C; Institut für Transfusionsmedizin, Universitätsmedizin Greifswald, 17475 Greisfwald, Germany.
Sobotta F; Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, Faculty of Medicine, Medical Center-University of Freiburg, 79106 Freiburg, Germany.
Schilling FH; Children's Hospital, Kantonsspital Luzern, 6000 Lucerne, Switzerland.
Morgan NV; Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK.
Freson K; Department of Cardiovascular Sciences, Center for Molecular and Vascular Biology, KU Leuven, 3000 Leuven, Belgium.
Rivera J; Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Pascual Parrilla, CIBERER-U765, 30003 Murcia, Spain.
Zieger B; Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, Faculty of Medicine, Medical Center-University of Freiburg, 79106 Freiburg, Germany.
Pokaż więcej
Źródło:
Cells [Cells] 2022 Oct 14; Vol. 11 (20). Date of Electronic Publication: 2022 Oct 14.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
GATA1 Transcription Factor*/genetics
GATA1 Transcription Factor*/metabolism
Thrombocytopenia*/genetics
Zinc Fingers*/genetics
Genetic Diseases, X-Linked*/genetics
Genetic Variation*
Anemia, Dyserythropoietic, Congenital*/genetics
Humans ; Male ; Integrins/metabolism ; Phenotype ; Blood Platelets/pathology
SCR Disease Name:
Thrombocytopenia 1
Czasopismo naukowe
Tytuł:
Postauthorization safety surveillance study of antihaemophilic factor (recombinant) reconstituted in 2 mL sterile water for injection in children with haemophilia A.
Autorzy:
Motwani J; Birmingham Children's Hospital, Birmingham, UK.
Guillet B; IRSET, Rennes University Hospital and Inserm U1085, Rennes, France.
Blatny J; Children's University Hospital Brno, Brno, Czech Republic.
Schilling FH; Luzerner Kantonsspital, Lucerne, Switzerland.
Wibaut B; CRTH, Institut Coeur Poumon, CHU, Lille, France.
Goldstine J; Baxalta US Inc., a member of the Takeda group of companies, Lexington, MA, USA.
Nagy A; Baxalta Innovations GmbH, a member of the Takeda group of companies, Vienna, Austria.
Doralt J; Baxalta Innovations GmbH, a member of the Takeda group of companies, Vienna, Austria.
Engl W; Baxalta Innovations GmbH, a member of the Takeda group of companies, Vienna, Austria.
Tangada S; Baxalta US Inc., a member of the Takeda group of companies, Lexington, MA, USA.
Spotts G; Baxalta US Inc., a member of the Takeda group of companies, Lexington, MA, USA.
Pokaż więcej
Źródło:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2020 May; Vol. 26 (3), pp. 478-486. Date of Electronic Publication: 2020 Apr 27.
Typ publikacji:
Journal Article
MeSH Terms:
Factor VIII/*therapeutic use
Hemophilia A/*drug therapy
Water/*chemistry
Child ; Child, Preschool ; Epidemiological Monitoring ; Factor VIII/pharmacology ; Female ; Humans ; Infant ; Infant, Newborn ; Injections ; Male
Czasopismo naukowe
    Wyświetlanie 1-11 z 11

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies